US launches Germany pharma pricing probe, raising threat of new tariffs

Germany came under fresh US trade scrutiny on Thursday as the United States launched an investigation into the country's pharmaceutical pricing policies, a move that could pave the way for new tariffs. Washington said it would examine whether Germany's pricing practices unfairly underpay for innovative medicines and burden US commerce under Section 301 trade authorities. What is this page? The website you are visiting is protected. For security reasons this page cannot be displayed.